QURE
Uniqure NV
NASDAQ: QURE · HEALTHCARE · BIOTECHNOLOGY
$16.73
-7.31% today
Updated 2026-04-29
Market cap
$1.05B
P/E ratio
—
P/S ratio
65.51x
EPS (TTM)
$-3.46
Dividend yield
—
52W range
$9 – $72
Volume
3.4M
Uniqure NV (QURE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-21.65M | $-14.91M | $-5.71M | $-30.92M | $18.78M | $-72.19M | $-64.27M | $-76.04M | $-98.68M | $-134.83M | $287.96M | $-145.06M | $-145.93M | $-182.73M | $-177.96M |
| Capital expenditures | $400492.00 | $1.25M | $8.27M | $23.27M | $9.41M | $17.17M | $5.58M | $4.25M | $6.65M | $9.48M | $17.44M | $17.69M | $7.15M | $3.37M | $439000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.22M | $2.34M | $2.79M | $11.51M | $8.34M | $6.21M | $10.13M | $10.71M | $17.53M | $21.83M | $25.64M | $34.20M | $35.09M | $22.26M | $17.68M |
| Free cash flow | $-22.05M | $-16.16M | $-13.98M | $-54.19M | $9.36M | $-89.36M | $-69.85M | $-80.28M | $-105.33M | $-144.31M | $270.52M | $-162.75M | $-153.08M | $-186.10M | $-178.40M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-89.13M | — | $77.68M | $143.49M | $-136.87M | $315.43M | — | — | — | — |